Dual expression of α-tocopherol-associated protein and estrogen receptor in normal/benign human breast luminal cells and the downregulation of α-tocopherol-associated protein in estrogen-receptor-positive breast carcinomas

12Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The hormonal carcinogenesis of breast cancer involves hormone-driven cell proliferation and genetic alterations, including oncogene activation and suppressor gene inactivation. However, the predominant genes involved in these processes are currently unknown. Our previous studies identified a gene, namely α-tocopherol-associated protein, which is preferentially expressed in normal/benign breast and prostate tissue, but its expression is downregulated in breast and prostate carcinomas. To further examine its function in hormone-induced carcinogenesis, we examined if there is an association between α-tocopherol-associated protein and estrogen-receptor expression in normal/benign breast tissue and in human breast carcinomas. We found that α-tocopherol-associated protein is coexpressed with estrogen receptor in the luminal cells of normal/benign breast tissue in a scattered manner by immunohistochemical staining of consecutive tissue sections of 20 cases, whereas α-tocopherol-associated protein expression is downregulated in 46% (45 of 98) of estrogen-receptor/progesterone-receptor-positive, so-called luminal type A or B human breast carcinoma. This is similar to the association of α-tocopherol-associated protein and androgen receptor expression in normal/benign prostate and prostate carcinomas. In contrast,α-tocopherol- associated protein expression is mostly negative in basal, Her2 and triple-negative nonbasal subtypes of high-grade breast carcinomas. These findings are consistent with α-tocopherol-associated protein acting as an antiproliferative factor in estrogen-receptor-positive luminal cells in normal/benign breast tissue. α-Tocopherol-associated protein downregulation may have triggered hormonal carcinogenesis in at least some of the breast carcinomas, providing further, albeit indirect evidence to support a role for vitamin E in breast cancer prevention. © 2009 USCAP, Inc. All rights reserved.

Author supplied keywords

References Powered by Scopus

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

2235Citations
N/AReaders
Get full text

Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype

1015Citations
N/AReaders
Get full text

Hormonal carcinogenesis

817Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Proteomic portrait of human breast cancer progression identifies novel prognostic markers

128Citations
N/AReaders
Get full text

Vitamin E: A Role in Signal Transduction

109Citations
N/AReaders
Get full text

Gene expression profiling reveals new aspects of PIK3CA mutation in eralpha-positive breast cancer: Major implication of the Wnt signaling pathway

57Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Johnykutty, S., Tang, P., Zhao, H., Hicks, D. G., Yeh, S., & Wang, X. (2009). Dual expression of α-tocopherol-associated protein and estrogen receptor in normal/benign human breast luminal cells and the downregulation of α-tocopherol-associated protein in estrogen-receptor-positive breast carcinomas. Modern Pathology, 22(6), 770–775. https://doi.org/10.1038/modpathol.2009.24

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 4

40%

Professor / Associate Prof. 3

30%

Researcher 3

30%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 5

45%

Biochemistry, Genetics and Molecular Bi... 3

27%

Medicine and Dentistry 2

18%

Chemistry 1

9%

Save time finding and organizing research with Mendeley

Sign up for free